{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:48:23Z","timestamp":1762606103094},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T00:00:00Z","timestamp":1333411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1741-7015-10-32","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T10:58:36Z","timestamp":1333450716000},"source":"Crossref","is-referenced-by-count":10,"title":["Crosstalk between HIV and hepatitis C virus during co-infection"],"prefix":"10.1186","volume":"10","author":[{"given":"Paul J","family":"Rider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenyong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,3]]},"reference":[{"issue":"1","key":"514_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","volume":"8","author":"EA Operskalski","year":"2011","unstructured":"Operskalski EA, Kovacs A: HIV\/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Curr HIV\/AIDS Rep. 2011, 8 (1): 12-22. 10.1007\/s11904-010-0071-3.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"514_CR2","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(03)14881-7","volume":"362","author":"N Alatrakchi","year":"2003","unstructured":"Alatrakchi N, Koziel MJ: A tale of two viruses: hepatitis C in the age of HAART. Lancet. 2003, 362: 1687-1688. 10.1016\/S0140-6736(03)14881-7.","journal-title":"Lancet"},{"key":"514_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7150\/ijms.3.47","volume":"3","author":"SL Chen","year":"2006","unstructured":"Chen SL, Morgan TR: The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006, 3: 47-52.","journal-title":"Int J Med Sci"},{"key":"514_CR4","unstructured":"Global Summary of the HIV\/AIDS epidemic, December 2010. [ http:\/\/www.who.int\/hiv\/data\/2011_epi_core_en.png ]"},{"key":"514_CR5","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-M\u00f8ller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD: Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006, 166: 1632-1641.","journal-title":"Arch Intern Med"},{"key":"514_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1086\/321909","volume":"33","author":"CS Graham","year":"2001","unstructured":"Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ: Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001, 33: 562-569. 10.1086\/321909.","journal-title":"Clin Infect Dis"},{"key":"514_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/157016207779316341","volume":"5","author":"C Parodi","year":"2007","unstructured":"Parodi C, Belmonte L, Bare P, de Bracco MM, Ruibal-Ares B: Impact of human immune deficiency virus infection on hepatitis C virus infection and replication. Curr HIV Res. 2007, 5: 55-67. 10.2174\/157016207779316341.","journal-title":"Curr HIV Res"},{"key":"514_CR8","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1002\/hep.1840360706","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff LB: Natural history of chronic hepatitis C. Hepatology. 2002, 36: S35-S46.","journal-title":"Hepatology"},{"issue":"9397","key":"514_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/S0140-6736(03)14844-1","volume":"362","author":"N Qurishi","year":"2003","unstructured":"Qurishi N, Kreuzberg C, L\u00fcchters G, Effenberger W, Kupfer B, Sauerbruch T, Rockstroh JK, Spengler U: Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet. 2003, 362 (9397): 1708-1713. 10.1016\/S0140-6736(03)14844-1.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"514_CR10","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/sj.cdd.4401164","volume":"10","author":"G Antonucci","year":"2003","unstructured":"Antonucci G, Goletti D, Lanini S, Girardi E, Loiacono O: HIV\/HCV co-infection: putting the pieces of the puzzle together. Cell Death Differ. 2003, 10 (Suppl 1): S25-S26.","journal-title":"Cell Death Differ"},{"key":"514_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","volume":"26","author":"B Soto","year":"1997","unstructured":"Soto B, S\u00e1nchez-Quijano A, Rodrigo L, del Olmo JA, Garc\u00eda-Bengoechea M, Hern\u00e1ndez-Quero J, Rey C, Abad MA, Rodr\u00edguez M, Sales Gilabert M, Gonz\u00e1lez F, Mir\u00f3n P, Caruz A, Relimpio F, Torronteras R, Leal M, Lissen E: Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol. 1997, 26: 1-5.","journal-title":"J Hepatol"},{"key":"514_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1086\/520935","volume":"196","author":"B Roe","year":"2007","unstructured":"Roe B, Coughlan S, Hassan J, Grogan A, Farrell G, Norris S, Bergin C, Hall WW: Elevated serum levels of interferon-gamma-inducible protein-10 in patients coinfected with hepatitis C virus and HIV. J Infect Dis. 2007, 196: 1053-1057. 10.1086\/520935.","journal-title":"J Infect Dis"},{"issue":"1","key":"514_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cyto.2011.10.020","volume":"57","author":"J Berenguer","year":"2012","unstructured":"Berenguer J, Fernandez-Rodr\u00edguez A, Jimenez-Sousa MA, Cos\u00edn J, Zarate P, Micheloud D, L\u00f3pez JC, Miralles P, Catal\u00e1n P, Resino S: High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV\/HCV coinfected patients. Cytokine. 2012, 57 (1): 25-29. 10.1016\/j.cyto.2011.10.020.","journal-title":"Cytokine"},{"key":"514_CR14","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.3748\/wjg.14.7149","volume":"14","author":"JR Larrubia","year":"2008","unstructured":"Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T: Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol. 2008, 14: 7149-7159. 10.3748\/wjg.14.7149.","journal-title":"World J Gastroenterol"},{"key":"514_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1182\/blood-2005-01-0126","volume":"106","author":"D Butera","year":"2005","unstructured":"Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB: Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood. 2005, 106: 1175-1182. 10.1182\/blood-2005-01-0126.","journal-title":"Blood"},{"issue":"3","key":"514_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/labinvest.3780248","volume":"81","author":"MA Garc\u00eda-L\u00f3pez","year":"2001","unstructured":"Garc\u00eda-L\u00f3pez MA, S\u00e1nchez-Madrid F, Rodr\u00edguez-Frade JM, Mellado M, Acevedo A, Garc\u00eda MI, Albar JP, Mart\u00ednez C, Marazuela M: CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest. 2001, 81 (3): 409-418. 10.1038\/labinvest.3780248.","journal-title":"Lab Invest"},{"key":"514_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/JVI.01388-08","volume":"83","author":"KJ Helbig","year":"2009","unstructured":"Helbig KJ, Ruszkiewicz A, Lanford RE, Berzsenyi MD, Harley HA, McColl SR, Beard MR: Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol. 2009, 83: 836-846. 10.1128\/JVI.01388-08.","journal-title":"J Virol"},{"issue":"18","key":"514_CR18","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1097\/QAD.0b013e3283324344","volume":"23","author":"A Balagopal","year":"2009","unstructured":"Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS: Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. Aids. 2009, 23 (18): 2397-2404. 10.1097\/QAD.0b013e3283324344.","journal-title":"Aids"},{"key":"514_CR19","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","volume":"55","author":"AD Frankel","year":"1988","unstructured":"Frankel AD, Pabo CO: Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988, 55: 1189-1193. 10.1016\/0092-8674(88)90263-2.","journal-title":"Cell"},{"issue":"1","key":"514_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1172\/JCI40594","volume":"121","author":"A Casrouge","year":"2011","unstructured":"Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML: Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest. 2011, 121 (1): 308-317. 10.1172\/JCI40594.","journal-title":"J Clin Invest"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-10-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-10-32\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-10-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T15:24:00Z","timestamp":1474471440000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-10-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-10-32","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,3]]},"article-number":"32"}}